Filing Flows › Insmed (INSM) › Q1 2025
Insmed (INSM) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Insmed (INSM) reported revenue of $92.8M for the first quarter 2025 (Q1 2025), +23% from a year earlier and -11% from the quarter before. Operating margin was -267.3%, net loss $257M (276.4% of revenue).
Insmed, Q1 2025: revenue $92.8M (+23% year over year), operating margin -267.3%, net loss $257M, operating cash flow −$262M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $92.8M | -11% | +23% |
| Operating profit | −$248M | — | — |
| Net earnings | −$257M | — | — |
| Operating cash flow | −$262M | — | — |
What changed
Revenue was $92.8M in Q1 2025, up 23% year over year and down 11% from the previous quarter.
Operating costs exceeded revenue by $248.1M, an operating margin of -267.3%. Total costs grew 54% against revenue growth of 23%. The quarter ended with a net loss of $256.6M, wider than the previous quarter's $235.5M loss.
Operating cash flow was −$262.1M. Non-cash charges added back $3.1M of depreciation and amortization and $39.3M of share-based compensation. Working capital and other items used $47.9M. Capital expenditures of $10.1M exceeded it, leaving free cash flow of −$272.2M.
Questions
What was Insmed's revenue in the first quarter 2025?
Insmed (INSM) reported revenue of $92.8M for the first quarter 2025 (Q1 2025), +23% from a year earlier and -11% from the quarter before.
Was Insmed profitable in the first quarter 2025?
Operating loss was $248M (-267.3% of revenue) and net loss $257M.
Source: Insmed 10-Q on SEC EDGAR.